These results suggest that loss of TRIM8 expression may be necessary for the transition to a more aggressive phenotype typical of WHO grade III gliomas as compared with WHO grade II tumours, but it may have less effect on the clinical behaviour of GBMs, suggesting a likely role of TRIM8 gene in gliomagenesis and disease progression. The gene discussed is TRIM8; the disease is neoplasm.